These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5637312)

  • 41. The microenvironment of human breast with clinical cancer.
    Sarnelli R; Squartini F
    Appl Pathol; 1983; 1(6):323-32. PubMed ID: 6679791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women.
    Fryzek JP; Ye W; Nyrén O; Tarone RE; Lipworth L; McLaughlin JK
    Breast Cancer Res Treat; 2006 May; 97(2):131-4. PubMed ID: 16328720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship of hair dye use, benign breast disease, and breast cancer.
    Nasca PC; Lawrence CE; Greenwald P; Chorost S; Arbuckle JT; Paulson A
    J Natl Cancer Inst; 1980 Jan; 64(1):23-8. PubMed ID: 6928044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oncoplastic approach to early breast cancer in women with macromastia.
    Jones JA; Pu LL
    Ann Plast Surg; 2007 Jan; 58(1):34-8. PubMed ID: 17197939
    [No Abstract]   [Full Text] [Related]  

  • 46. Benign breast disease and breast cancer.
    Kristiansen IS; Christensen PM; Gyrd-Hansen D
    N Engl J Med; 2005 Oct; 353(17):1856-8; author reply 1856-8. PubMed ID: 16252414
    [No Abstract]   [Full Text] [Related]  

  • 47. Cohort study of women at risk for breast cancer and gross cystic disease.
    Chun J; Joseph KA; El-Tamer M; Rundle A; Jacobson J; Schnabel F
    Am J Surg; 2005 Oct; 190(4):583-7. PubMed ID: 16164926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclical mastalgia and breast cancer risk: results of a French cohort study.
    Plu-Bureau G; Lê MG; Sitruk-Ware R; Thalabard JC
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1229-31. PubMed ID: 16775187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
    Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ
    Cancer; 2006 Sep; 107(6):1240-7. PubMed ID: 16902983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benign breast disease and breast cancer.
    Koss LG; Fineberg S
    N Engl J Med; 2005 Oct; 353(17):1856-8; author reply 1856-8. PubMed ID: 16251545
    [No Abstract]   [Full Text] [Related]  

  • 51. The prevalence of benign breast disease in women with polycystic ovary syndrome: a review of a 12-year follow-up.
    Soran A; Talbott EO; Zborowski JV; Wilson JW
    Int J Clin Pract; 2005 Jul; 59(7):795-7. PubMed ID: 15963207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease.
    Gallicchio L; McSorley MA; Newschaffer CJ; Thuita LW; Huang HY; Hoffman SC; Helzlsouer KJ
    Cancer; 2006 Apr; 106(7):1443-52. PubMed ID: 16502408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Benign breast disease among first-degree relatives of young breast cancer patients.
    Bertelsen L; Mellemkjaer L; Balslev E; Olsen JH
    Am J Epidemiol; 2008 Aug; 168(3):261-7. PubMed ID: 18525080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast diseases in the Northern region of Saudi Arabia.
    Chiedozi LC; El-Hag IA; Kollur SM
    Saudi Med J; 2003 Jun; 24(6):623-7. PubMed ID: 12847591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Multiple epidermoid cysts in fibrocystic breast disease and intraductal fibroadenoma].
    Ferlito A; Mainini F; Natali R
    Riv Anat Patol Oncol; 1970; 36(1-4):106-18. PubMed ID: 5523604
    [No Abstract]   [Full Text] [Related]  

  • 56. Fibrocystic "disease" of the breast.
    N Engl J Med; 1983 Mar; 308(12):722-3. PubMed ID: 6828114
    [No Abstract]   [Full Text] [Related]  

  • 57. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
    Geiger AM; Yu O; Herrinton LJ; Barlow WE; Harris EL; Rolnick S; Barton MB; Elmore JG; Fletcher SW
    Arch Intern Med; 2005 Mar; 165(5):516-20. PubMed ID: 15767526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
    Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
    J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy.
    Geiger AM; West CN; Nekhlyudov L; Herrinton LJ; Liu IL; Altschuler A; Rolnick SJ; Harris EL; Greene SM; Elmore JG; Emmons KM; Fletcher SW
    J Clin Oncol; 2006 Mar; 24(9):1350-6. PubMed ID: 16549829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormone replacement therapy and the risk of breast lesions that predispose to cancer.
    Cahn MD; Tran T; Theur CP; Butler JA
    Am Surg; 1997 Oct; 63(10):858-60. PubMed ID: 9322657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.